The document discusses succession planning in organizations. It describes succession planning as identifying and grooming future leaders to replace current leaders. Some benefits include avoiding ill-timed promotions, developing leadership internally, and ensuring a smooth transition. It also discusses the specific succession planning process at Ranbaxy Laboratories, where Mr. Brar announced his retirement plans in advance and his replacement, Dr. Brian Tempest, was appointed smoothly according to the succession plan.